On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1330 AM Sheboygan, WI

Weather

Current Conditions(Sheboygan,WI 53081)

More Weather »
47° Feels Like: 43°
Wind: WNW 8 mph Past 24 hrs - Precip: 0.05”
Current Radar for Zip

Tonight

Rain 39°

Tomorrow

AM Clouds/PM Sun 60°

Sat Night

Mostly Clear 36°

Alerts

China should probe foreign luxury carmakers over prices: Xinhua

SHANGHAI (Reuters) - Foreign carmakers are reaping exorbitant profits selling imported luxury cars in China and should face an anti-trust investigation, the official Xinhua News Agency said, in what may amount to a shot across the bow of foreign auto firms.

Xinhua said that in the wake of investigations into how foreign companies in other sectors price their goods, the question of imported cars had become a contentious topic.

Foreign milk formula makers and pharmaceutical companies have come under intense regulatory scrutiny in recent weeks, especially over pricing. Separately, Chinese police have accused British drugmaker GlaxoSmithKline of bribery.

Analysts, however, said they did not expect foreign carmakers to become the latest target of China's focus on prices.

"Milk powder pricing is a more imperative problem, as it's baby food and concerns ... families," said Yale Zhang, managing director of Automotive Foresight (Shanghai) Co Ltd, a consultancy and industry research firm.

"Luxury cars are different. Some people in China have plenty of money and are indifferent to high pricing."

China has become a key market for the makers of luxury cars, with 2.7 million expected to be sold each year by 2020, overtaking the United States as the world's leader in the segment.

The Xinhua report said some imported cars were twice as expensive in China than in overseas markets.

It cited a man surnamed Qu who had bought an Audi Q7 in Canada for 78,000 Canadian dollars, or about 460,000 yuan ($75,000), and who was shocked to see the same car on sale in China for 1 million yuan.

It also said similar price differences existed between some unspecified Land Rover models made by Jaguar Land Rover as well as the BMW X5 . JLR is owned by India's biggest carmaker by revenue, Tata Motors Ltd .

Xinhua did not make clear where it got the price information it cited. The automakers could not immediately be reached for comment.

"PROFITEERING"

Selling imported cars in China was 30 percent more profitable than the global average, Xinhua said, citing Rao Da, secretary general of the China Passenger Car Association.

He added that foreign carmakers exercised monopolies over the sales and service channels of imported cars.

Zhang Min, president of the Waigaoqiao car supermarket in Shanghai, was quoted as saying that while the government imposed a tax on luxury cars, the difference between prices paid in China and overseas amounted to "profiteering".

Rao later told Reuters he thought it was unlikely the government would investigate the luxury car market.

"Foreign carmakers have chosen to set prices of luxury cars excessively high in China, where the rising ranks of the rich are willing to buy expensive foreign brands to show off their wealth, and where there are no domestic luxury brands to compete with," Rao said.

He added that opinions voiced in the Xinhua article might be partly driven by the fact that some domestic automakers are envious of the profits earned by foreign luxury brands.

Earlier this month top western milk formula makers Nestle SA , Danone , Mead Johnson Nutrition Co and Abbott Laboratories said they were being investigated by China's top economic planning agency for possible anti-trust violations.

Chinese authorities are also probing the pricing practices at top local and international drugmakers, including units of GlaxoSmithKline and Merck , while a number of gold shops are also being investigated for price fixing.

GSK is also embroiled in bribery allegations after police detained four of its Chinese executives in connection with accusations the drugmaker funneled up to 3 billion yuan ($489 million) to travel agencies to facilitate bribes to doctors and officials. GSK has said some of its Chinese executives appeared to have broken the law.

(Reporting by Samuel Shen and Jonathan Standing Editing by Dean Yates)

Comments